Shaping the future of human possibilities

#Sustainability

With its four-leaf clover symbol and its Sustainability Manifesto, IBSA confirms its founding values – which are in perfect harmony with the ESG goals – while strengthening its commitment to the well-being of people, the environment and the community.

Discover more

Our latest News

Discover more

TRACE: a global meeting point for advanced training and “Made in IBSA” innovation

Aree Terapeutiche

13 December 2024

TRACE: a global meeting point for advanced training and “Made in IBSA” innovation

Sailing into the Future

12 December 2024

Sailing into the Future. Together: an extraordinary adventure comes to an end, but the journey continues

Top 300 Lodi: IBSA Italy is the only pharmaceutical company among the top 10 local businesses

Corporate

06 December 2024

Top 300 Lodi: IBSA Italy is the only pharmaceutical company among the top 10 local businesses

IBSA Italy invests in the Cassina de' Pecchi plant to respond to the international market

Corporate

05 December 2024

IBSA Italy invests in the Cassina de' Pecchi plant to respond to the international market

Three years of inclusive sailing and a sea of solidarity: the journey with the Para Sailing Academy continues

Corporate Social Responsibility

04 December 2024

Three years of inclusive sailing and a sea of solidarity: the journey with the Para Sailing Academy continues

Twelfth Report Donare per curare (“Donating to cure”): 436,000 people are in conditions of health poverty

Corporate Social Responsibility

28 November 2024

Twelfth Report Donare per curare (“Donating to cure”): 436,000 people are in conditions of health poverty

Discover more

IBSA at the glance

IBSA (Institut Biochimique SA) is a Swiss multinational pharmaceutical company, founded in 1945 in Lugano. Today, our products are present in over 90 Countries on 5 continents, with 18 subsidiaries in Europe, China and the United States.

Discover more

90Countries

Main markets: Switzerland, EU, USA, Middle East, Far East and North Africa

20Subsidiaries

Austria, Belgium, Baltic countries, China, Czech Republic, France, Germany, Hong Kong SAR, Hungary, Spain/Portugal, Italy, Netherlands, Nordic countries, Poland, Singapore, Slovakia, Switzerland, Turkey, UK, USA

+ 2,300Employees

worldwide

10Therapeutic Areas

Reproductive medicine
Endocrinology
Pain and Inflammation
Osteoarticular
Aesthetic Medicine
Dermatology
Uro-ginaecology
Cardiometabolic
Respiratory
Consumer Health

Shaping the future of human possibilities

#Sustainability

Our latest News

TRACE: a global meeting point for advanced training and “Made in IBSA” innovation

Sailing into the Future. Together: an extraordinary adventure comes to an end, but the journey continues

Top 300 Lodi: IBSA Italy is the only pharmaceutical company among the top 10 local businesses

IBSA Italy invests in the Cassina de' Pecchi plant to respond to the international market

Three years of inclusive sailing and a sea of solidarity: the journey with the Para Sailing Academy continues

Twelfth Report Donare per curare (“Donating to cure”): 436,000 people are in conditions of health poverty

IBSA at the glance

Our pillars

Person

Innovation

Quality

Responsibility

Documenti istituzionali

Corporate Brochure
(80 MB)

Technologies Brochure
(87 MB)

Sustainability Report
(13 MB)

Shaping the future of human possibilities

#Sustainability

Our latest News

TRACE: a global meeting point for advanced training and “Made in IBSA” innovation

Sailing into the Future. Together: an extraordinary adventure comes to an end, but the journey continues

Top 300 Lodi: IBSA Italy is the only pharmaceutical company among the top 10 local businesses

IBSA Italy invests in the Cassina de' Pecchi plant to respond to the international market

Three years of inclusive sailing and a sea of solidarity: the journey with the Para Sailing Academy continues

Twelfth Report Donare per curare (“Donating to cure”): 436,000 people are in conditions of health poverty

IBSA at the glance

Our pillars

Person

Innovation

Quality

Responsibility

Documenti istituzionali

Corporate Brochure(80 MB)

Technologies Brochure(87 MB)

Sustainability Report(13 MB)

Corporate Brochure
(80 MB)

Technologies Brochure
(87 MB)

Sustainability Report
(13 MB)